Antipsychotic-like effects of zolpidem in Wistar rats

详细信息    查看全文

• 作者：Pawel Mierzejewski^a ; ^{mierzeje@ipin.edu.pl" class="auth_mail" title="E-mail the corresponding author} ; Marcin Kolaczkowski^b ; ^c ; Monika Marcinkowska^b ; Anna Wesolowska^b ; Jerzy Samochowiec^d ; Maciej Pawlowski^b ; Przemyslaw Bienkowski^a
• 关键词：Zolpidem ; GABAA receptors ; Antipsychotic-like effects ; Animal models of psychosis ; Rats
• 刊名：European Journal of Pharmacology
• 出版年：2016
• 出版时间：15 February 2016
• 年：2016
• 卷：773
• 期：Complete
• 页码：51-58
• 全文大小：981 K

文摘

Aside from their use in the treatment of anxiety disorders and insomnia, benzodiazepines and other GABA_A receptor positive modulators are widely used as add-on treatments in schizophrenic and non-schizophrenic psychoses. However, there is relatively little direct clinical or pre-clinical evidence for antipsychotic effects of GABAergic medications. Previous studies have indicated that zolpidem, a GABAergic drug acting preferentially at α1-containing GABA_A receptors, may produce catalepsy through interactions with dopaminergic neurotransmission. The aim of the present study was to investigate effects of zolpidem in experimental models of antipsychotic activity and extrapyramidal side effects in Wistar rats. Effects of zolpidem were compared with that of a classic benzodiazepine drug, diazepam and a second-generation antipsychotic medication, risperidone. High doses of risperidone (10.0 mg/kg, i.p.) and zolpidem (10.0 mg/kg, i.p.), but not diazepam, induced relatively short-lasting cataleptic responses in the bar test. Zolpidem and risperidone, but not diazepam, produced some antipsychotic-like effects at doses, which produced no catalepsy and did not inhibit spontaneous locomotor activity and apomorphine-induced stereotypies. The present results tend to indicate that zolpidem exerts some neuroleptic-like effects at doses, which do not produce motor side effects. Our findings may provide further rationale for the development of new subtype-selective GABA_A receptor modulators for the treatment of psychotic symptoms.